Adaptive Platform Treatment Trial For Outpatients With Covid-19
Principal Investigator(s)
Email for information
Funded by
Geneva
Research Start Date
Status
Active
This RDTE project will benefit the Collaborating Party by accomplishing its mission to promote and support the advancement of military medicine and specifically military medical research. The RDTE project will benefit the BAMC by providing valuable research experience for the staff involved. In addition, patients at BAMC with COVID-19 may benefit from the medical treatment.
The appearance of name-brand products in this article does not constitute endorsement by Brooke Army Medical Center, the U.S. Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of Defense, or the U.S. Government of the information, products, or services contained therein.